Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyuekang Tablet is an approved traditional Chinese medicine (TCM) tablet developed by Shaanxi Momentum Pharmaceutical. It is formulated with a blend of traditional Chinese herbs, including Angelica sinensis (Danggui), Ligusticum chuanxiong (Chuanxiong), Glycyrrhiza uralensis (Gancao), Prunus persica (Taoren), Zingiber officinale (Ganjiang), Leonurus japonicus (Yimucao), Carthamus tinctorius (Honghua), and Cynanchum paniculatum (Xuchangqing). Fuyuekang Tablet is indicated for the treatment of lochiorrhagia (postpartum lochia retention), lower abdominal pain, vaginal bleeding, and hypermenorrhea (excessive menstrual bleeding) caused by a contraceptive ring. It functions by promoting blood circulation, removing blood stasis, and relieving pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuyuekang Tablet.